3rd Annual Digestive Diseases : New Advances

The complexity and magnitude of medical advances in the management of digestive diseases make it ever more challenging for clinicians to apply this tremendous amount of information to their practice. This knowledge-based activity will provide learners with a comprehensive overview of the state-of-the-art advances in the diagnostic, therapeutic and preventive modalities of digestive diseases based on the latest evidence, literature, and clinical research.

A thorough review of the current treatment landscape is vital to both clinicians and patients who can benefit from the expansion of therapeutic options. This conference is designed for gastroenterologists, primary care physicians, advanced practice nurses, nurses, pharmacists, and physician assistants involved in the diagnosis, evaluation, management, and treatment of patients with digestive diseases.

LEARNING OBJECTIVES :
Upon completion of this activity, participants should be better able to:
• Review the most current perspectives and clinical guidelines for the use of biologic agents in inflammatory bowel disease (IBD)
• Identify various IBD risk factors, including a patient’s level of immune suppression, which influence the timing of surgery
• Review the pathophysiology, epidemiology, and clinical presentation of hepatocellular carcinoma
• Assess the need of management strategies of patients with hepatic encephalopathy
• Differentiate irritable bowel syndrome (IBS) from other common gastrointestinal disorders
• Implement diagnostic and management strategies for IBS
• Recognize the clinical presentation of ischemic colitis for early identification and treatment